Engineered swine cutaneous growth protein (rrhEGF) is gaining increased recognition as a key approach in the area of tissue medicine. This bioactive agent, produced through recombinant engineering, delivers a https://recombinant-porcine-egf148047.justblogstop.com/421783/recombinant-porcine-cutaneous-growth-factor-a-effective-method-for-tissue-regeneration